- Home
- AMR vs AXSM Comparison
AMR vs AXSM Comparison
Compare AMR & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMR | AXSM |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 5.9B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | AMR | AXSM |
|---|---|---|
| Price | $207.18 | $147.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 20 |
| Target Price | $168.00 | ★ $176.00 |
| AVG Volume (30 Days) | 278.0K | ★ 476.7K |
| Earning Date | 11-06-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,226,356,000.00 | $561,263,000.00 |
| Revenue This Year | N/A | $66.20 |
| Revenue Next Year | $17.77 | $57.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 65.83 |
| 52 Week Low | $97.41 | $75.56 |
| 52 Week High | $217.25 | $152.94 |
Technical Indicators
Market Signals| Indicator | AMR | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 69.39 | 55.38 |
| Support Level | $180.38 | $145.07 |
| Resistance Level | $194.32 | $149.13 |
| Average True Range (ATR) | 10.19 | 4.18 |
| MACD | 3.15 | -0.76 |
| Stochastic Oscillator | 93.33 | 59.59 |
Price Performance
Historical ComparisonAbout AMR Alpha Metallurgical Resources Inc.
Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.